Biomarkers Market Size Worth USD 88,605.25 Million by 2030 at 10.80% CAGR - Report by Market Research Future (MRFR)
October 28, 2022 09:30 ET
|
Market Research Future
New York, USA, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Biomarkers Market Overview: According to a Comprehensive Research Report by Market Research Future (MRFR), “Biomarkers Market Information by...
Elixiron Immunotherapeutics Receives Grant From the Alzheimer's Association to Trial Microglia-Targeting Immunotherapy
July 12, 2022 11:01 ET
|
Elixiron Immunotherapeutics
SAN FRANCISCO, July 12, 2022 (GLOBE NEWSWIRE) -- Elixiron Immunotherapeutics, a clinical stage drug development company announced today that it has received a new grant from the Alzheimer's...
North America DNA Sequencing Market Anticipated to Garner a Revenue of $9,154 million and Grow at a Healthy CAGR of 15.9% during the Estimated Timeframe from 2019 to 2025 [200-Pages] | Revealed by Research Dive
June 28, 2022 09:00 ET
|
Research Dive
New York, USA, June 28, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the North America DNA Sequencing Market is envisioned to generate a revenue of $9,154 million and...
Global Digital Biomarkers Market is set to witness a significant CAGR of 35% from 2021 to 2026
May 16, 2022 09:30 ET
|
Medi-Tech Insights
Brussels, Belgium, May 16, 2022 (GLOBE NEWSWIRE) -- Description: Digital biomarkers are indexes that use data from digital platforms such as smartphones and wearable devices to objectively...
Standard BioTools Announces First Quarter 2022 Financial Results
May 05, 2022 16:02 ET
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – unleashing tools to accelerate breakthroughs in human health – today...
Neuronascent Releases Further Positive Results of NNI-362 in A Randomized Phase 1a Trial for Alzheimer’s Disease
March 30, 2022 06:00 ET
|
Neuronascent, Inc.
ROCKVILLE, Md., March 30, 2022 (GLOBE NEWSWIRE) -- Neuronascent Inc., is a clinical-stage pharmaceutical company discovering and developing novel regenerative therapies for age-related brain...
Biomarkers In Cancer Targeted Immunotherapy
March 15, 2022 03:53 ET
|
KuicK Research
Delhi, March 15, 2022 (GLOBE NEWSWIRE) -- Global Breast Cancer Antibodies Biomarkers & Clinical Trials Insight 2028 Report Highlights: Global Breast Cancer Antibodies Market Opportunity:...
Cognition Therapeutics to Present Analyses from Clinical Studies of CT1812 in Patients with Alzheimer’s Disease at AD/PD 2022
March 10, 2022 07:30 ET
|
Cognition Therapeutics, Inc.
NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical stage neuroscience company developing drugs that treat age-related degenerative diseases of the...
Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results
February 17, 2022 17:43 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Inotiv, Inc. and Synexa Life Sciences Sign Letter of Intent to Establish Center of Excellence for Biotherapeutics and Biomarkers
January 04, 2022 08:33 ET
|
Inotiv, Inc.
-- Expected to establish a leading global provider of full-spectrum, preclinical and clinical biotherapeutics and biomarker analysis solutions -- -- Expected to enhance scale, broaden customer base...